This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Tempus Ai, Inc., Tempus Labs, Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Yilin Zhang: Innovator in Therapeutic Sensitivity Prediction
Introduction
Yilin Zhang is an accomplished inventor based in Wilmette, IL (US). He has made significant contributions to the field of therapeutic sensitivity prediction, holding a total of 4 patents. His work focuses on utilizing organoid cultures to enhance treatment predictions and outcomes.
Latest Patents
Yilin Zhang's latest patents include innovative systems and methods for predicting therapeutic sensitivity. These methods, systems, and software leverage organoid cultures, particularly patient-derived tumor organoid cultures, to improve treatment predictions and outcomes. Another notable patent is centered on large-scale organoid analysis, which also aims to enhance treatment predictions and outcomes through similar methodologies.
Career Highlights
Throughout his career, Yilin Zhang has worked with prominent companies such as Tempus Labs, Inc. and Tempus AI, Inc. His expertise in organoid cultures and therapeutic sensitivity has positioned him as a key figure in the research and development of advanced treatment methodologies.
Collaborations
Yilin has collaborated with talented individuals in his field, including Ameen Salahudeen and Verónica Sánchez Freire, who is a notable woman in the industry.
Conclusion
Yilin Zhang's innovative work in therapeutic sensitivity prediction through organoid cultures showcases his dedication to improving treatment outcomes. His contributions are paving the way for advancements in personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile